Giant viruses encode protein-making tools for host control

A new study reveals that giant viruses, like the mimivirus, encode parts of the cellular protein-making machinery, allowing them to direct their amoeba hosts more effectively. This capability blurs the line between living and non-living entities. Researchers suggest it enhances viral production even under stressful conditions.

Giant viruses have intrigued biologists since 2003, when a mimivirus was identified in a water sample from Bradford, UK. This virus, which infects amoebae, is larger than many bacteria and features intricate structures along with hundreds of genes.

Typically, viruses depend on host cells to produce proteins, but some giant viruses incorporate elements of the translation machinery—the process that converts genetic information into proteins—directly into their genomes. Translation involves ribosomes and initiation complexes in cells.

Max Fels at Harvard Medical School and colleagues investigated this in infected amoebae. They isolated ribosomes from these cells and found associated viral proteins. “That was the first hint that they could be the factors we were looking for,” says Fels.

To test the role of these viral proteins, the team modified the virus's genes to prevent their production. This reduced viral output by up to 100,000-fold and severely limited new infectious particle formation.

The findings indicate that the viral complex redirects the host's protein-synthesis system toward producing viral proteins, functioning even during nutrient shortages or oxidative stress, which normally hinder host protein synthesis.

This raises evolutionary questions: did giant viruses evolve from ancient cells, or did they acquire genes from hosts? “Giant viruses have acquired a wide range of cellular machinery from their eukaryotic hosts throughout their evolution,” notes Frank Aylward at Virginia Tech, who was not involved in the study. Gene transfer during infections, followed by natural selection, likely preserved beneficial genes.

Such viruses target single-celled hosts like amoebae, where environments vary more than in multicellular organisms, making adaptable protein control advantageous.

The mimivirus genome codes for about 1,000 proteins, but most functions remain unknown, including precise regulation during infection cycles. “Viruses have long been considered rather passive entities in the evolution of living systems,” says Hiroyuki Ogata at Kyoto University in Japan. “This study shows that giant viruses can reshape molecular systems that are otherwise stably conserved across the domains of life.”

The research appears in Cell (DOI: 10.1016/j.cell.2026.01.008).

Awọn iroyin ti o ni ibatan

Microscopic image depicting a rabies virus protein shape-shifting to bind RNA and access cellular compartments, illustrating viral control in host cells for antiviral development.
Àwòrán tí AI ṣe

Shape‑shifting protein helps explain how rabies virus commandeers host cells

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

Australian researchers report that a rabies virus protein changes shape and binds RNA to access liquid-like cellular compartments, offering a unifying explanation for how the virus exerts broad control with few genes. The work, published October 29, 2025, in Nature Communications, could inform future antivirals and vaccines, the team says.

Scientists in Japan have discovered a giant virus called ushikuvirus that infects amoebae and provides evidence for the theory that viruses contributed to the evolution of complex cells. Isolated from Lake Ushiku, the virus exhibits unique structural and replication traits linking it to other giant DNA viruses. This finding, published in the Journal of Virology, deepens understanding of viral roles in eukaryotic evolution.

Ti AI ṣe iroyin

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

Researchers have discovered a protein called Aurora-related kinase 1 (ARK1) that is vital for the malaria parasite's cell division. Disabling ARK1 in experiments halted the parasite's ability to replicate in both human and mosquito hosts. The finding, published in Nature Communications, highlights a potential target for new antimalarial drugs.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

Scientists from the universities of Cambridge and Glasgow have shown why many bird flu viruses can keep replicating at fever-like temperatures that typically curb human flu. A study in Science identifies the viral PB1 gene as crucial to this heat tolerance, raising concerns about pandemic risks if such genes move into human strains.

Scientists at the University of Queensland have captured the first near‑atomic, high‑resolution 3D images of the yellow fever virus, detailing how the surface of the long‑used vaccine strain differs from virulent, disease‑causing strains. The work sheds light on how the virus is recognised by the immune system and could support improved vaccines for yellow fever and related mosquito‑borne diseases.

Ti AI ṣe iroyin

Researchers at the University of California, Berkeley have identified a methane-producing archaeon that interprets a standard stop codon in two ways, challenging a core principle of biology. The microbe, Methanosarcina acetivorans, sometimes adds an amino acid called pyrrolysine instead of halting protein synthesis. This flexibility may aid in metabolizing compounds linked to human health.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ